UBS O'Connor’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-14,635
Closed -$768K – 650
2023
Q2
$839K Sell
14,635
-15,917
-52% -$831K 0.02% 400
2023
Q1
$1.15M Sell
30,552
-12,831
-30% -$473K 0.03% 390
2022
Q4
$1.16M Buy
43,383
+6,849
+19% +$187K 0.02% 550
2022
Q3
$1.03M Sell
36,534
-3,000
-8% -$83.6K 0.01% 744
2022
Q2
$858K Buy
39,534
+4,534
+13% +$127K 0.01% 781
2022
Q1
$1.41M Buy
+35,000
New +$1.46M 0.02% 645

Other funds holding MORF

UBS O'Connor's MORF Position: Q3 2023 in Review

UBS O'Connor sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2023, closing a stake of 14,635 shares — an estimated $768K sold.

UBS O'Connor first reported a position in MORF in Q1 2022 and held it in 6 quarters. The position peaked at $1.41M in Q1 2022. 134 funds tracked by Wall St. Rank hold MORF as of Q3 2023.

  • UBS O'Connor reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 14,635 Morphic Holding, Inc. Common Stock shares in Q3 2023, an estimated $768K.
  • UBS O'Connor first reported a position in Morphic Holding, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • UBS O'Connor's Morphic Holding, Inc. Common Stock position peaked at $1.41M in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.